Research ArticleAUTOIMMUNITY

PTPN22 inhibition resets defective human central B cell tolerance

See allHide authors and affiliations

Science Immunology  22 Jul 2016:
Vol. 1, Issue 1, pp. aaf7153
DOI: 10.1126/sciimmunol.aaf7153

Article Information

vol. 1 no. 1 aaf7153

PubMed: 
Published By: 
History: 
  • Received March 21, 2016
  • Accepted June 17, 2016

Author Information

  1. Jean-Nicolas Schickel1,
  2. Marcel Kuhny1,
  3. Alessia Baldo1,
  4. Jason M. Bannock1,
  5. Christopher Massad1,
  6. Haowei Wang1,
  7. Nathan Katz1,
  8. Tyler Oe1,
  9. Laurence Menard1,
  10. Pauline Soulas-Sprauel2,
  11. Till Strowig1,*,
  12. Richard Flavell1,3 and
  13. Eric Meffre1,
  1. 1Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06511, USA.
  2. 2CNRS UPR 3572, Laboratory of Immunopathology and Therapeutic Chemistry/Laboratory of Excellence Medalis, Molecular and Cellular Biology Institute (IBMC), Strasbourg, France.
  3. 3Howard Hughes Medical Institute, Chevy Chase, MD 20815–6789, USA.
  1. Corresponding author. Email: eric.meffre{at}yale.edu
  • * Present address: Helmholtz Centre for Infection Research, Braunschweig, Germany.

Altmetric

Article usage

Article usage: July 2016 to December 2017

AbstractFullPdf
Jul 20161249405400
Aug 2016884147154
Sep 2016258416
Oct 20162381844
Nov 2016142816
Dec 20161772032
Jan 2017150820
Feb 20171571213
Mar 2017138713
Apr 2017100510
May 20171441113
Jun 2017146410
Jul 20179555
Aug 2017177911
Sep 201713948
Oct 2017134513
Nov 2017110814
Dec 20177356